Our independence: SlimBee has absolutely no commercial relationship with any pharmacy or prescriber — including any organisation mentioned on this page. We mention specific pharmacies because we admire their charitable and community work, never for commercial gain. We earn no commission or referral fees from any link on this site.
At a glance
In the UK, you can access Mounjaro (tirzepatide) and Wegovy (semaglutide) through several types of provider — each with different regulatory oversight, prescribing processes, support levels, and costs. Understanding these differences protects your safety and helps you ask the right questions. This guide covers independent prescribers, Patient Group Direction (PGD) services, large-chain online pharmacies, CQC-regulated clinics, doctor-led private services, and NHS routes — with a comparison table and a practical decision guide.
Why your choice of provider matters
Choosing where to access Mounjaro or Wegovy is not simply a question of price. The prescribing process, the depth of medical assessment, the quality of ongoing clinical support, and the safety standards of medication storage and delivery all vary meaningfully between types of provider.
These aren't abstract considerations. We've heard from many people who received inadequate assessments, were prescribed medication that interacted with something they were already taking, or received medication that hadn't been properly cold-chained. None of this needed to happen. Understanding the landscape helps you ask the right questions and make an informed choice.
Equally, we want to reassure you: many UK online pharmacies operate to an excellent standard. GPhC registration is a meaningful safeguard, and the majority of registered providers do carry out proper consultations. This guide is about empowering you to identify the good ones — not about creating fear.
The two non-negotiable checks for any UK online pharmacy
1. GPhC registration: Verify independently at pharmacyregulation.org — not just from the logo on their site.
2. Proper individual consultation: The service must conduct a real medical assessment — not just a checkbox questionnaire with auto-approval — before any prescription is issued.
Independent prescribers
An independent prescriber is a healthcare professional — typically a doctor (GMC-registered), pharmacist prescriber (GPhC-registered), or nurse prescriber (NMC-registered) — who is authorised to assess, diagnose, and prescribe across a defined area of practice without needing a direction from another clinician.
When an independent prescriber assesses you for weight-loss medication, they are making a clinical decision specific to you — reviewing your history, examining your current medications for interactions, considering your individual risk factors, and selecting an appropriate treatment. This is different from supplying medication under a protocol (see PGD services below).
Independent prescribers carry the highest level of individual clinical authority. They are legally and professionally accountable for every prescribing decision they make. Whether they practise in person, via an NHS clinic, or through an online service, they assess you as an individual rather than applying a group protocol.
- Full individual clinical assessment for every patient
- Highest level of personal accountability for the prescriber
- Can prescribe for patients who don't fit a standard protocol
- Can adjust treatment based on evolving clinical picture
- May offer greater continuity of care
- Able to manage complex cases with comorbidities
- Cost varies widely — often higher for face-to-face consultations
- Availability can be limited outside major cities
- Quality still varies between individual practitioners
- Online independent prescribers still need GPhC/CQC registration
Patient Group Direction (PGD) services
A Patient Group Direction (PGD) is a written clinical protocol, authorised by a senior doctor and pharmacist, that allows certain registered healthcare professionals to supply or administer a specific medicine to groups of patients who meet defined criteria — without requiring an individual prescription to be written for each patient.
What this means in practice
Under a PGD, the healthcare professional who supplies the medication is following a pre-approved protocol rather than making a fully independent clinical judgement about your individual case. The protocol sets out who is eligible (e.g. "adults with BMI ≥30") and the healthcare professional checks whether you meet those criteria. This is a legitimate and widely used model in the UK — it underpins NHS flu vaccinations, emergency hormonal contraception, and many other services — but it can mean a less personalised clinical assessment than you'd receive from an independent prescriber who considers your full individual picture.
PGD services are common in UK online pharmacy models. A pharmacist or nurse checks that you meet the eligibility criteria in the protocol, and if you do, supplies the medication. This is not the same as an independent prescriber reviewing your case holistically — but when the PGD is well-written and the eligibility check is thorough, it can still be a safe and appropriate model for straightforward cases.
- Often faster and more streamlined than IP services
- Frequently lower consultation costs
- Widely used and legally established model in the UK
- Appropriate for patients with straightforward eligibility
- Subject to MHRA and GPhC oversight
- Less personalised than an independent prescribing assessment
- May not handle edge cases or complex histories as well
- Quality of PGD protocols varies between services
- Not all services are transparent about whether they use PGDs
Large chain & online pharmacies
Several well-known UK pharmacy brands offer online prescribing services for Mounjaro and Wegovy. Each has a somewhat different model — some employ independent prescribers directly, others use a PGD-based approach, some use a hybrid. Speed, pricing, depth of consultation, and support quality vary.
The advantages of large chains include brand recognition, regulatory scrutiny, and often better-developed support resources. The disadvantages can include a more transactional feel, higher volumes meaning less personalised attention, and variable quality between individual prescribers within the same organisation.
One of the UK's largest pharmacy chains. Their online doctor service offers weight management prescriptions including Mounjaro and Wegovy following an online consultation. Boots' scale means significant regulatory scrutiny and generally consistent standards.
Superdrug's online doctor service has been providing GLP-1 prescriptions since Wegovy's UK launch. Known for a streamlined online process. Consultation is digital-first; clinical review is conducted by registered clinicians.
One of the UK's largest NHS-approved online pharmacies, Pharmacy2U also offers private prescribing services for weight management. Strong reputation for dispensing accuracy and cold-chain delivery management.
LloydsPharmacy has a dedicated online doctor service operating independently of their retail pharmacy estate. Offers weight management prescriptions via online consultation, with an emphasis on ongoing monitoring and support.
MedExpress (operating under the ZAVA brand) is one of Europe's largest digital health companies. Fast consultation turnaround is a core part of their model. Regulatory standards are high; the trade-off is a more rapid, lower-touch experience.
Treated.com is a well-established UK online health platform covering weight management and many other conditions. They use clinician review of online consultations and have invested in their clinical support offer for GLP-1 treatments.
Our position on chain pharmacies
SlimBee does not rank or endorse specific pharmacies. The profiles above are informational overviews based on publicly available information and are not a recommendation. Always verify current GPhC registration and conduct your own assessment of any service. pharmacyregulation.org is the definitive verification source.
CQC-regulated clinics & providers
The Care Quality Commission (CQC) is the independent regulator of health and social care in England. Any provider offering a "regulated activity" — which includes remote clinical prescribing — must be registered with the CQC.
CQC registration means the provider has been assessed against fundamental standards of safety, effectiveness, caring, responsiveness, and well-led governance. Registered providers are subject to inspection and can be required to make improvements or, in serious cases, have their registration suspended.
This is important: GPhC registration covers the dispensing of medication. CQC registration covers the clinical assessment and prescribing activity. Both matter. A service with only GPhC registration dispenses safely. A service with both GPhC and CQC registration is subject to oversight of both its dispensing and its clinical process.
A CQC-registered provider offering weight-loss injections has undergone regulatory inspection of both its clinical processes and its governance structure. This is a meaningful additional safeguard that not all online pharmacies hold. When a service provides online prescribing and dispensing, CQC registration for the prescribing activity is a strong positive signal.
Scotland, Wales and Northern Ireland
The CQC operates in England only. In Scotland, healthcare services are regulated by Healthcare Improvement Scotland (HIS). In Wales, by Healthcare Inspectorate Wales (HIW). In Northern Ireland, by the Regulation and Quality Improvement Authority (RQIA). If you're accessing services from a provider in one of these nations, look for registration with the appropriate body.
- Subject to independent inspection of clinical standards
- Must meet fundamental standards of safety and effectiveness
- Accountable for clinical governance, not just dispensing
- Can be reported to CQC if standards drop
- Inspection reports are publicly available on cqc.org.uk
- CQC registration alone doesn't guarantee quality — check inspection ratings
- Some providers hold CQC registration but inspection ratings vary
- Not applicable outside England (different body required)
Doctor-led private weight-loss services
At the premium end of the private market, some services offer a genuinely comprehensive weight management programme — rather than simply a prescription and a medication supply. These typically involve a multidisciplinary team, including a specialist in obesity medicine, and may include dietitian input, psychological support, and structured follow-up.
This model most closely replicates what you would receive from a well-resourced NHS Tier 3 service, but delivered privately. The cost is considerably higher — but for some people, particularly those with complex clinical pictures or who want the most thorough support, it may be the most appropriate option.
Doctor-led private services typically involve a detailed initial consultation with a specialist, comprehensive baseline investigations (blood tests, body composition, cardiovascular risk assessment), an ongoing monitoring programme, and access to allied health professionals. Some also offer group support programmes or psychological therapy. This is a very different proposition from an online prescription service.
- Most thorough clinical assessment available outside NHS
- MDT support may include dietitian, psychologist, specialist
- Ongoing monitoring programme built in
- Appropriate for complex cases
- Support structure for maintaining results long-term
- Closest private equivalent to NHS Tier 3
- Significantly higher cost (often £300–600+ for initial assessment)
- Medication costs on top of clinic fees
- Less accessible outside major cities
- Quality varies — red flags still apply (see below)
- Minimal consultation — a brief online questionnaire with automatic approval
- No discussion of your complete medication list and potential interactions
- No follow-up monitoring or check-in structure after prescribing
- Aggressive upselling of multiple supplements, tests, or treatments
- Pressure tactics, urgency language, or "limited time" offers
- Unable to provide CQC registration or the prescriber's GMC number
- Selling "generic Mounjaro" or unlicensed compounds — these do not exist legally in the UK
NHS routes
Both Mounjaro and Wegovy have received NICE approval for NHS use — Mounjaro under TA1026 (2023) and Wegovy under TA875 (2023). However, the practical reality of NHS access in 2025 remains limited for most people.
NHS access offers the highest level of clinical oversight available — specialists in obesity medicine, dietitian support, psychological input, and structured follow-up programmes, at no direct cost to you. The challenge is access: most people currently cannot access NHS-funded Mounjaro or Wegovy without meeting stringent criteria and often waiting significant periods.
NHS Tier 3 specialist weight-management services
This is the primary route to NHS-funded GLP-1 medication. To be referred, you typically need: a GP referral, a BMI of 35+ (or 30–34.9 with significant comorbidities), evidence of engagement with a structured lifestyle programme, and to live in an area where your Integrated Care Board has commissioned the service. Waiting times can be considerable.
NHSE primary care pilot
As of 2025, a limited pilot is providing Mounjaro through some NHS primary care settings. This is not universally available. Your GP will know whether your area is participating. The eligibility criteria for the pilot are similar to Tier 3 but the pathway is more streamlined.
Hospital-based obesity and metabolic medicine clinics
For people with more complex needs — significant comorbidities, very high BMI, history of bariatric surgery — referral to a hospital-based clinic may be appropriate. These clinics can prescribe Mounjaro or Wegovy as part of a broader medical management plan.
- Free at point of use (NHS prescription charges may apply)
- Highest level of multidisciplinary clinical support
- Ongoing monitoring and follow-up built into service
- Appropriate for complex cases and significant comorbidities
- Psychological support often included
- Access is severely limited in most areas ("postcode lottery")
- Significant waiting times in many ICBs
- Eligibility criteria can exclude people with moderate need
- GP may be unaware of or unconfident about referral pathway
Want the full NHS access guide?
Our dedicated guide covers eligibility criteria, the postcode lottery, how to approach your GP, and what to do if access isn't available in your area. Read our full NHS Mounjaro and Wegovy guide →
Full comparison table: all UK provider types
The table below summarises the key characteristics of each provider type across the dimensions that matter most for safety and quality of care.
| Provider Type | Regulatory Oversight | Prescriber Type | Assessment Depth | Speed | Ongoing Support | Approximate Cost |
|---|---|---|---|---|---|---|
| Independent Prescribers | GMC/GPhC/NMC + GPhC pharmacy + CQC (if remote) | Individual clinical decision by registered prescriber | ★★★★★ Most thorough | Days–weeks | Variable — depends on service | £150–£300+ consultation + medication |
| PGD Services | GPhC pharmacy + protocol approval | Protocol-based — registered HCP applies eligibility criteria | ★★★☆☆ Standard for eligible patients | Hours–days | Often limited | £149–£199 starter (medication-inclusive) |
| Large Chain Online Pharmacies | GPhC + CQC (varies by provider) | Mix of IP and PGD depending on service | ★★★☆☆ Consistent but often standardised | 1–3 days typical | App/portal-based — variable depth | £149–£250/month depending on dose |
| CQC-Regulated Clinics | GPhC + CQC + potentially NMC/GMC individual | Clinically reviewed individual assessment | ★★★★☆ Good depth + governance oversight | 2–5 days | Structured monitoring programmes | £150–£280/month all-in |
| Doctor-Led Private Clinics | GMC + CQC + GPhC (dispensing) + CCG/NHS-standard governance | Specialist physician — often consultant-level | ★★★★★ Most thorough private option | Days–weeks (appointments) | MDT, dietitian, monitoring programme | £300–£600 initial + medication ongoing |
| NHS Tier 3 Services | NHS England + CQC + NICE | Specialist MDT — consultant, dietitian, psychologist | ★★★★★ Highest available | Weeks–months wait | Structured MDT programme | Free at point of use |
| NHS Primary Care Pilot | NHS England + CQC + NICE | GP or primary care prescriber | ★★★☆☆ Good — GP-level assessment | Weeks (limited availability) | GP-managed — varies | Free at point of use (NHS Rx charges may apply) |
Assessment depth ratings are relative, not absolute — all regulated providers must meet minimum safety standards. CQC inspection ratings for individual services can be checked at cqc.org.uk. Costs are approximate and based on SlimBee market research, June 2025. SlimBee earns no commission from any provider.
Which type is right for you?
There is no single answer that fits everyone. The right provider for you depends on your individual circumstances, priorities, and medical history. What follows is a framework to help you think it through — not a prescription.
Universal safety checklist
Regardless of which type of provider you choose, the following checks apply to every service. Use this checklist before you provide any personal information or make any payment.
Frequently asked questions
An independent prescriber is a registered clinician (doctor, pharmacist prescriber, or nurse prescriber) who makes a fully individual clinical judgement about your care — reviewing your specific medical history, current medications, and clinical picture.
A Patient Group Direction (PGD) is a written protocol that allows a healthcare professional to supply medicine to patients who meet specific eligibility criteria, without an individual prescription. Under a PGD, the clinician checks whether you meet the criteria in the protocol — they are not making a fresh individual clinical assessment.
Both models are legal and widely used in the UK. Independent prescribing typically offers more personalised assessment; PGD-based services are often faster and lower cost. For patients with straightforward eligibility and no complex medical history, a well-run PGD service can be entirely appropriate.
GPhC registration is the minimum requirement for any pharmacy that dispenses medication in the UK. CQC registration applies when a provider is carrying out a "regulated activity" — which includes remote clinical prescribing in England. A service that both prescribes and dispenses online should hold both GPhC and CQC registrations.
CQC registration is a meaningful additional safeguard because it means the clinical process (not just the dispensing) is subject to independent inspection. You can check any provider's CQC registration at cqc.org.uk.
Neither generic Mounjaro nor compounded semaglutide is licensed in the UK. The MHRA has issued specific warnings about unlicensed semaglutide products, citing risks including impurities, incorrect dosing, and lack of quality controls. "Compounded semaglutide" and "generic tirzepatide" marketed for weight loss are not legal in the UK.
The only licensed versions are Mounjaro (manufactured by Eli Lilly) and Wegovy or Ozempic (manufactured by Novo Nordisk). Any service selling unlicensed alternatives is operating outside the law.
No. SlimBee has no commercial relationship, referral arrangement, affiliate programme, or revenue-sharing scheme with any pharmacy, prescriber, or manufacturer.
SlimBee earns revenue through display advertising from non-healthcare brands, clearly disclosed on our advertising policy page. No pharmacy or healthcare company has any commercial influence over our content. Read our full independence statement →
Before using any service, consider asking: Who will conduct my consultation, and what are their qualifications? Is this an independent prescribing consultation or a PGD? Are you CQC-registered? How is the medication stored and delivered — is it cold-chain? What happens if I experience a side effect — how do I access clinical support? What is the full cost, and are there any recurring charges I need to be aware of?
A legitimate, high-quality service will be happy to answer all of these questions clearly and without evasion.
Medical disclaimer: This article is for general informational purposes and does not constitute medical advice, diagnosis, or treatment. Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines. Always consult a GMC-registered prescriber before starting, changing, or stopping medication. SlimBee has no commercial ties to any pharmacy or prescriber. Regulatory information reflects publicly available guidance as of June 2025. References: GPhC guidance on internet pharmacies; CQC fundamental standards; NICE TA1026; NICE TA875; MHRA Medicines Safety Update (semaglutide). Full medical disclaimer →